Skip to main content

REACH Project Scientific Publications

REACH Project Scientific Publications

The Adolescent Medicine HIV/AIDS Research Network was supported by the National Institute of Child Health and Human Development, with supplemental funding from the National Institutes on Drug Abuse, Allergy and Infectious Diseases, and Mental Health and the Health Resources and Services Administration.

2013

80. 5 U01 HD32842 Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA. Int J STD AIDS. 2013; 24:123-127. PMID:23467290 [PubMed - as supplied by publisher]

81. 5 U01 HD32842 Mullins TLK, Wilson CM, Rudy BJ, Sucharew H, and Kahn JA. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sexually Transmit Dis. 2013. 40(9):715-720.

82. 5 U01 HD32842 Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S. Variants in Interleukin Family of Cytokines and Toll-Like Receptor Genes Influence Clearance of High Risk HPV in HIV-1 Co-infected African-American Adolescents. Human Immunology, in press.

83. 5 U01 HD32842 Johnson DC, Shrestha S, Wiener HW, Makowsky R, Kurundkar A, Wilson CM, Aissani B. Mitochondrial DNA diversity in the African American Population of the REACH Cohort. Provisionally accepted by Mitochondrial DNA.

2012

78. 5 U01 HD32842 Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan E, Shrestha S. Transitional Probability-Based Model for HPV Clearance in HIV-1-Positive Adolescent Females. Plos ONE 2012;7 (1) e30736. doi:10.1371/journal.pone.0030736

79. 5 U01 HD32842 Sudenga SL, Kempf MC, McGwin G, Wilson CM, Hook III E, Shrestha S. Incidence, Prevalence and Epidemiology of Herpes Simplex Virus-2 in HIV-1-positive and HIV-1-negative Adolescents. Sexually Transmit Dis 2012; 39 (4): 300-305.

2011

76. 5 U01 HD32842 Song W, Li Y, Wilson CM and Tang J. Identification of three immunologic correlates for HIV type 1 pathogenesis in youth. AIDS Res Human Retroviruses. 2011; 27 (6): 639-646. PMCID pending.

77. 5 U01 HD32842 Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, McNicholl JM, Gardner LI, Wilson CM, Klein RS, Rompalo A, Mayer K5, Sobel J and Kaslow RA for the HIV Epidemiology Research Study Group and Reaching for Excellence in Adolescent Care and Health Study Group. The Influence of HLA Class I Alleles and their Population Frequencies on HIV-1 Control Among African Americans. Human Immunology, 2011; 72 (4): 312-318.

2010

73. 5 U01 HD32842 Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, Gardner LI, McNicholl JM, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J and Kaslow RA for the HIV Epidemiology Research Study and Reaching for Excellence in Adolescent Care and Health Study. Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans. J Virol 2010; 84 (5):2610-2617.

74. 5 U01 HD32842 Shrestha S, Sudenga SL, Smith JS Bachmann LH, Wilson CM, and Kempf MC. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomarvirus infections in HIV-positive adolescents. BMC Infectious Diseases 2010, 10:295.

75. 5 U01 HD32842 Shrestha S, Wiener HW, Aissani B, Song W, Shendre A, Wilson CM, Kaslow RA, and Tang J. Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents. PLoS ONE, 2010: 5 (10): e13384. doi:10.1371/journal.pone.0013384. PMC2954785

2009

70. 5 U01 HD32842 Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009; 23(6):673-677.

71. Tsai CS, Shepherd BE, Vermund SH. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol 2009;200:38.e1-38.e8.

72. 5 U01 HD32842 Ding H, Wilson CM, Modjarrad K, McGwin G Jr, Tang J, Vermund SH. Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the Reaching for Excellence in Adolescent Care and Health (REACH) project. Arch Pediatr Adolesc Med 2009; 163(12):1100-5. PubMed PMID: 19996046.

2008

69. 5 U01 HD32842 Geisler WM, Wang C, Tang J, Wilson CM, Crowley-Nowick PA, Kaslow RA. Immunogenetic Correlates of Neisseria gonorrhoeae Infection in Adolescents. Sex Transm Dis 2008; 35(7):656-661.

2007

66. 5 U01 HD32842 Stephensen CB, Marquis GS, , Douglas SD, Kruzich LA, Wilson CM. Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 2007;85:173-181.

67. 5 U01 HD32842 Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, and Kaslow RA. CCL3L1 and CCL4L1: Variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun 2007;8:224-231.

68. 5 U01 HD32842 Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA. Interleukin-10 gene (IL10) Polymorphisms and Human Papillomavirus Clearance among Immunosuppressed Adolescents. Cancer Epidemiol Biomarkers Prev 2007; 16:1626-32.

2006

61. 5 U01 HD32842 Stephensen CB, Marquis GS, Jacob RA, Kruzich LA, Douglas SD, Wilson CM. Vitamins C and E in adolescents and young adults with HIV infection. Am J Clin Nutr 2006;83:870-879.

62. 5 U01 HD32842 Song W, Wilson CM, Allen S, Wang C, Li Y, Kaslow RA, and Tang J. Interleukin 18 and human immunodeficiency virus type 1 infection in adolescents and adults. Clin Exp Immunol 2006;144:117-124.

63. 5 U01 HD32830 Moscicki AB, Ellenberg JH, Murphy DA, Jiahong X. Associations among body composition, androgen levels, and human immunodeficiency virus status in adolescents. J Adolesc Health 2006;39:164-173.

64. 5 U01 HD32842 Shao W, Lazaryan A, Dorak MT, Penman-Aguilar A, Wilson CM, Margolick J, Goedert J, Prins M, Tang J, Kaslow R. Cohort and Time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS, 2006;20:1583-1590.

65. 5 U01 HD32830 Casper C, Meier AS, Wald A, Morrow RA, Corey L, Moscicki AB. Human Herpesvirus 8 Infection Among Adolescents in the REACH Cohort. Arch Pediatr Adolesc Med, 2006;160: 937-942.

2005

55. 5 U01 HD32842 Stephensen CB, Marquis GS, Douglas SD, Wilson, CM. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acq Immune Defic Synd 2005;38(2):180-190.

56. 5 U01 HD32842 Bansal A, Gough E, Sabbaj S, Ritter D, Yusim K, Sfakianos G, Aldrovandi G, Kaslow RA, Wilson CM, Mulligan MJ, Kilby JM, Goepfert PA. CD8+ T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS 2005;19:241-250.

57. 5 U01 HD32842 Wang C, Tang, J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infections in high-risk adolescents. J Infect Dis 2005;191:1084-1092.

58. 5 U01 HD32842 Stephensen CM, Marquis GS, Douglas SD, Wilson CM. Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: A protective role for IL-10? Free Radic Res 2005;39(8):859-864.

59. 5 U01 HD32827 Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, for the Adolescent Medicine HIV/AIDS Research Network. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 2005;159:764-770.

60. 5 U01 HD32842 Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Divergent Endocervical TH1 Cytokine Responses to Chlamydia trachomatis Infection in Adolescents. Clin Exp Immunol 2005; 142:548-554.

2004

47. 5 U01 HD32842 Wang C, Song W, Lobashevsky E, Wilson CM, Douglas S, Mytilineos J, Schoenbaum EE, Tang J, Kaslow RA. Cytokine and chemokine gene polymorpshisms among ethnically diverse North Americans with human immunodeficiency virus type 1 (HIV-1) infection. J Acq Immune Defic Syndr 2004;35:446-454.

48. 5 U01 HD32842 Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA. CD8+CD38+ T cells but not HIV-1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses 2004;20(3):263-269. Correction AIDS Res Hum Retroviruses 2004;20:575.

49. 5 U01 HD32842 Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene polymorphisms are associated with differential responses to hepatitis B vaccination. Hepatology 2004;39(4):978-988.

50. 5 U01 HD32842 Kruzich LA, Marquis GS, Carriquirry AL, Wilson CM, Stephensen CB. U.S. youth in the early stage of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc 2004;104(7):1095-1101.

51. 5 U01 HD32842 Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIV-infected U.S. youth are at high risk of obesity and poor dietary quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc 2004;104(10):1554-1560. (Research editorial J Am Diet Assoc 2004;104(10):1549-1553).

52. 5 U01 HD32830 Moscicki AB, Ellenberg JH, Fahrat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and uninfected adolescent girls: risk factors and differences by phylogenetic types. J Infect Dis 2004; 190:37-45.

53. 5 U01 HD32830 Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Fahrat S. Risk of high grade squamous intra-epithelial lesions in HIV infected adolescents. J Infect Dis 2004;190:1413-1421.

54. 5 U01 HD32842 Geisler WM, Tang J, Wang C, Wilson CM, Kaslow RA. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in north American adolescents. J Infect Dis 2004;190:1723-1729.

2003

37. 5 U01 HD32830 Moscicki AB, Durako SJ, Yong M, Darragh T, Vermund SH. Utility of cervicography in human immunodeficiency virus infected and uninfected adolescents. J Adolesc Health 2003;32:204-213.

38. 5 U01 HD35752 Stanford PD, Monte DA, Briggs FM, Flynn PM, Tanney M, Ellenberg JH, Clingan KL, Rogers AS. Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health 2003;32:192-203.

39. 5 U01 HD32827 Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among HIV-infected adolescents. Arch Pediatr Adolesc Med 2003;157:249-255.

40. 5 U01 HD32842 Pham T, Belzer M, Church JA, Kitchen C, Wilson CM, Douglas SD, Geng Y, Silva M, Mitchell RM, Krogstad P. Assessment of thymic activity in HIV negative and positive adolescents using real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol 2003;10:323-328.

41. 5 U01 HD32842 Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, Wilson CM for the Adolescent Medicine HIV/AIDS Research Network. Cytokine mRNA and protein for TH1 and TH2 Cytokines in HIV seropositive and HIV seronegative youth. Clin Diagn Lab Immunol 2003;10:399-404.

42. 5 U01 HD32830 Moscicki AB, Houser J, Ma Y, Murphy DA, Darragh T, Farhat S, Wilson CM. Human papillomavirus infection and abnormal cytology of the anus in human immunodeficiency virus infected and uninfected adolescents. AIDS 2003;311-320.

43. 5 U01 HD32842 Douglas SD, Camarca M, Durako S, Murphy D, Moscicki B, Wilson C. The relationships between substance abuse, psychosocial variables and natural killer cell enumeration and function in HIV-infected and high risk uninfected adolescents. AIDS Res Hum Retroviruses 2003;19:399-408.

44. 5 U01 HD32842 Pahwa S, Chitnis V, Mitchell RM, Fernandez S, Chandrasekharan A, Wilson CM, Douglas SD. CD4 and CD8 T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy naive adolescents. AIDS Res Hum Retroviruses 2003;19(6):487-495.

45. 5 U01 HD32842 Sabbaj S, Bansal A, Ritter GD, Perkins C, Edwards BH, Gough E, Tang J, Szinger JJ, Korber B, Wilson CM, Kaslow RA, Mulligan MJ, Goepfert PA. Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. JAIDS 2003;33:426-438.

46. 5 U01 HD32842 Bansal A, Sabbaj S, Edwards BH, Ritter GD, Perkins C, Tang J, Szinger JJ, Weiss H, Goepfert PA, Korber B, Wilson CM, Kaslow RA, Mulligan MJ. T-cell responses in HIV Type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA Class I alleles. AIDS Res Hum Retroviruses 2003;19 (11):1017-1026.

2002

32. 5 U01 HD32842 Tang J, Wilson CM, Schaen M, Myracle A, Douglas SD, Kaslow RA for the REACH Study Group. Chemokine receptor CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. AIDS Res Hum Retroviruses 2002;18:403-412.

33. 5 U01 HD32827 Murphy DA, Mitchell R, Vermund SH, Futterman D. Factors associated with HIV testing among HIV-positive and HIV negative high-risk adolescents: the REACH Study. Pediatrics 2002;110:e36.

34. 5 U01 HD32828 Rudy BJ, Wilson CM, Durako S, Moscicki AB, Muenz L, Douglas SD. Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH Project. Clin Diagn Lab Immunol 2002;9:959-965.

35. 5 U01 HD32842 Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, Douglas SD, Korber B, Vermund SH, Kaslow RA. Host genetic profiles predict virologic and immunologic control of human immunodeficiency virus type 1 infection in adolescents. AIDS 2002;16:2275-2284.

36. 5 U01 HD32842 Starr SE, Sarr M, Campbell DE, Wilson CM, Douglas SD. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents. AIDS Res Hum Retroviruses 2002;18:1301-1310.

2001

13. 5 U01 HD32838 Belzer M, Rogers AS, Fuchs D, Camarca M, Tucker D, Peralta L, Durako S and the Adolescent Medicine HIV/AIDS Research Network. Contraceptive choices in HIV infected and HIV uninfected adolescent females. J Adolesc Health 2001;29S:93-100.

14. 5 U01 HD32866 D’Angelo LJ, Abdalian SE, Sarr M, Hoffman N, Belzer M and the Adolescent Medicine HIV/AIDS Research Network. Disclosure of serostatus by HIV infected youth: the experience in the REACH study. J Adolesc Health 2001;29S:72-79.

15. 5 U01 HD32842 Douglas SD, Durako SJ, Tustin NB, Houser J, Muenz L, Starr SE, Wilson C. Natural Killer cell enumeration and function in HIV infected and high risk uninfected adolescents. AIDS Res Hum Retroviruses 2001;17:543-552.

16. 5 U01 HD32833 Futterman DC, Rudy BJ, Peralta L, Wolfson S, Guttmacher S, Rogers AS and the ACCESS Project Team. The ACCESS Project (Adolescents Connected to Counseling, Evaluation, and Special Services): Social marketing to promote HIV testing to adolescents, methods and first year results from a six city campaign. J Adolesc Health 2001;29S:19-29.

17. 5 U01 HD32860 Levin L, Henry-Reid L, Murphy DA, Peralta L, Sarr M, Ma Y, Rogers AS and the Adolescent Medicine HIV/AIDS Research Network. Incident pregnancy rates in HIV infected and HIV uninfected at risk adolescents. J Adolesc Health 2001;29S:101-108.

18. 5 U01 HD32830 Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 2001;183:865-70.

19. 5 U01 HD32827 Murphy DA, Durako SJ, Moscicki AB, Vermund SH, Ma Y, Schwarz DF, Muenz L and the Adolescent Medicine HIV/AIDS Research Network. No change in health-risk behavior over time among HIV-infected adolescents in care: role of psychological distress. J Adolesc Health 2001;29S:57-63.

20. 5 U01 HD32827 Murphy DA, Wilson CM, Durako SD, Muenz L and Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001;13:27-40.

21. 5 U01 HD32857 Peralta L, Durako S, Ma Y and the Adolescent Medicine HIV/AIDS Research Network. Correlation between urine and cervical specimens for the detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae using Ligase Chain Reaction in a cohort of HIV infected and uninfected adolescents. J Adolesc Health 2001;29S:87-92.

22. 5 U01 HD32842 Rogers AS, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, Wilson CM. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus. Clin Diagn Lab Immunol 2001;8:273-278.

23. 5 U01 HD32842 Rogers AS, Miller S, Murphy DA, Tanney M, Fortune T and the TREAT Project Team. The TREAT Project (Therapeutic Regimens Enhancing Adherence in Teens): theory and preliminary results. J Adolesc Health 2001;29S:30-38.

24. 5 U01 HD32828 Rudy B, Douglas S, and Crowley-Nowick P. Immunology and the REACH study: HIV immunology, the research agenda, and preliminary findings. J Adolesc Health 2001;29S:39-48.

25. 5 U01 HD32828 Schwarz DF, Henry-Reid L, Houser J, Ma Y and the Adolescent Medicine HIV/AIDS Research Network. The association of perceived health, clinical status, and initiation of highly active antiretroviral therapy (HAART) in adolescents. J Adolesc Health 2001;29S:115-122.

26. 5 U01 HD32842, P01 DE07946, K15 DE00359. Shiboski C, Wilson CM, Greenspan D, Hilton J, Greenspan J, Moscicki AB and the Adolescent Medicine HIV/AIDS Research Network. HIV-Related oral manifestations among adolescents in a multicenter cohort study. J Adolesc Health 2001;29S:109-114.

27. 5 U01 HD32839 Sturdevant MS, Belzer M, Weissman G, Friedman LB, Sarr M, Muenz LR. The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. J Adolesc Health 2001;29S:64-71.

28. 5 U01 HD32842 Vermund SH, Sarr M, Murphy DA, Levin L, Abdalian SE, Ma Y, Crowley-Nowick P, Wilson CM and the Adolescent Medicine HIV/AIDS Research Network. Douching practices among HIV infected and uninfected adolescents in the United States. J Adolesc Health 2001;29S:80-86.

29. 5 U01 HD32842 Vermund SH, Wilson CM, Partlow C, Moscicki AB. High rates of sexually transmitted infections among HIV Infected and HIV uninfected youth: baseline prevalence and research agenda in the REACH Project. J Adolesc Health 2001;29S:49-56.

30. 5 U01 HD32842 Wilson CM, Ellenberg JH, Sawyer M, Belzer M, Crowley-Nowick P, Puga A, Futterman D, Peralta L. Serologic response to Hepatitis B vaccine in HIV-infected and high risk HIV uninfected adolescents in the REACH cohort. J Adolesc Health 2001;29S:123-129.

31. 5 U01 HD32842 Wilson CM, Houser J, Partlow C, Futterman DC, Rudy BJ, Friedman LB and the Adolescent Medicine HIV/AIDS Research Network. The REACH Project (Reaching for Excellence in Adolescent Care and Health): study design, methods, and population profile. J Adolesc Health 2001;29S:8-18.

2000

4. 5 U01 HD32842 Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000;181:939-945.

5. 5 U01 HD32842 Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson CM, Holland C, Crowley Nowick P, Vermund SH. T lymphocyte subsets in HIV-infected and high risk HIV-uninfected adolescents - Retention of naive T lymphocytes in HIV-infected adolescents. Arch Pediatr Adolesc Med 2000;154:375-80.

6. 5 U01 HD32867 Holland C, Ellenberg JH, Wilson C, Douglas SD, Futterman D, Kingsley L, Moscicki AB. The relationship of CD4+ T cell counts and HIV-1 viral loads in untreated, infected adolescents. AIDS Res Hum Retroviruses 2000;16:959-963. (short communication)

7. 5 U01 HD32867 Holland CA, Ma Y, Moscicki AB, Durako SJ, Levin L, Wilson CM. Seroprevalence and risk factors of Hepatitis B, Hepatitis C, and Human Cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the Reaching for Excellence in Adolescent Care and Health Study. Sex Transm Dis 2000;27:296-303.

8. 5 U01 HD32830 Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM. Prevalence of and risks for cervical human papillomavirus infection and squamous intra-epithelial lesions in adolescent women: Impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154:127-134.

9. 5 U01 HD32827 Murphy DA, Durako SD, Muenz L, Wilson CM. Marijuana use among HIV+ and high-risk adolescents: a comparison of self-report through Audio Computer-Assisted Self-Administered Interviewing and urinalysis. Am J Epidemiol 2000;152:805-813.

10. 5 U01 HD32827 Murphy DA, Moscicki AB, Vermund SH, Muenz L. Psychological distress among HIV-positive adolescents in the REACH study: Effects of life stress, social support, and coping. J Adolesc Health 2000;27:391-398.

11. 5 U01 HD32842 Rogers AS, Ellenberg JH, Douglas SD, Henry Reid L, Peralta L, Wilson C. The prevalence of anergy in human immunodeficiency virus infected adolescents and the association of delayed-type hypersensitivity with subject characteristics. J Adolesc Health 2000;27:384-390.

12. 5 U01 HD32842 Sullivan KE, Cutilli J, Piliero LM, Ghavimi-Alagha D, Starr SE, Campbell DE, Douglas SD. Measurement of cytokine secretion, intracellular protein expression and messenger RNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2000;8:920-924.

1999

2. 5 U01 HD32842 Douglas SD, Rudy B, Muenz L, Moscicki AB, Wilson CM, Holland C, Crowley Nowick P, Vermund SH. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. AIDS 1999;13:1629-1635.

3. 5 U01 HD32842 Rogers AS, Schwarz DF, Weissman G, English A. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs. IRB: A Review of Human Subjects Research 1999;21:6 10.

1998

1. 5 U01 HD32842 Rogers AS, Futterman D, Moscicki AB, Wilson C, Ellenberg J, and Vermund SH for the Adolescent Medicine HIV/AIDS Research Network. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health 1998;22:300-311.